Pretreatment Neutrophil-to-Lymphocyte Ratio Associated with Tumor Recurrence and Survival in Patients Achieving a Pathological Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer

Pretreatment Neutrophil-to-Lymphocyte Ratio Associated with Tumor Recurrence and Survival in Patients Achieving a Pathological Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer

The clinical influence of the neutrophil-to-lymphocyte ratio (NLR) in predicting outcomes in patients with locally advanced rectal cancer (LARC) who achieve a pathological complete response (pCR) to neoadjuvant chemoradiotherapy (NACRT) has seldom been investigated. We retrospectively recruited 102...

Full description

Bibliographic Details
Main Authors: Chun-Ming Huang, Ming-Yii Huang, Hsiang-Lin Tsai, Ching-Wen Huang, Wei-Chih Su, Tsung-Kun Chang, Yen-Cheng Chen, Ching-Chun Li, Jaw-Yuan Wang
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cancers
Subjects:
locally advanced rectal cancer
neoadjuvant chemoradiotherapy
neutrophil-to-lymphocyte ratio
prognostic factor
pathological complete response
Online Access:https://www.mdpi.com/2072-6694/13/18/4589

Internet

https://www.mdpi.com/2072-6694/13/18/4589

Similar Items